The Arrow ErgoPack® Complete System delivers a consistent way to reduce CLABSI1 per CDC guidelines
Featuring clinician inspired enhancements
You need the right solution for optimal catheter insertion efficiency. Our updated maximal barrier CVC insertion system puts necessary components in an intuitive configuration to help optimize your workflow, comply with CDC, SHEA, INS, and OSHA guidelines2-5, and fight against central line-associated bloodstream infections (CLABSI).
Check out what’s new...
Nitinol wire
Is kink-resistant compared to stainless steel
Arrow GlideWheel™ Advancer
Provides tactile feedback + finer control
Transducer cover
To support guidelines for ultrasound insertion
Pre-filled sterile saline syringe
One pre-filled sterile saline syringe per lumen now included inside the kit
Extra ChloraPrep® Skin Prep
Extra applicator now included in each kit
Everything for a Reason
We’re always thinking about what matters to you and your patients— it’s our entire product development philosophy, methodology and culture.
Take the next step:
References:
1. Raad, II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology. 1994;15(4 Pt 1): 231-238.
2. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). 2. Atlanta, GA: Centers for Disease Control and Prevention; 2017.
3. Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology. 2014 July; 35(7): 753-71.
4. Gorski L, Hadaway L, Hagle ME, McGoldrick M, et al. Infusion Therapy Standards of Practice. Journal of Infusion Nursing. 2016; Jan 39(1S).
5. Occupational Safety & Health Administration Regulations (Standards – 29 CFR). Part 1910.1030: Bloodborne pathogens. Occupational Safety & Health Administration Web site. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030. Accessed on February 12, 2020.
6. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine of Central Catheter-Related Infections. Ann Intern Medicine. 2005; 143: 570-80. Sponsored by Arrow (Teleflex).
7. Lorente L, Lecuona M, Jimenez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. American Journal of Infection Control. 2014; 42: 321-4.
8. Lorente L, Lecuona M, Jimenez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access.American Journal of Infection Control. 2014; 42: 1130-2.
9. Lorente, L, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. American journal of infection control. 2016; 44(12): 1526-29.
Contraindication:
The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.
Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. See Instructions for Use for detailed information regarding the instructions for use, contraindications, potential adverse events, warnings and cautions.
Chloraprep is a trademark or registered trademark of Becton, Dickinson and Company.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard, Arrowg+ard Blue Plus, ErgoPack, and GlideWheel are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.
Information in this material is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative. Revised: 10/2020.
© 2020 Teleflex Incorporated. All rights reserved. MC-006498 * Rev 0
